Iran Rashedi

发表

TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell‐Mediated Treg Induction via Notch Signaling

S. Viswanathan, A. Keating, A. Gómez-Aristizábal, 2016, Stem cells.

Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells

M. Radisic, B. Hinz, A. Keating, 2017, PloS one.

Ultrasound-Assisted Tissue Plasminogen Activator Delivery to Ischemic Strokes

G. Hortelano, Iran Rashedi, A. Thakura, 2012 .

Concise Review: TLR Pathway‐miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions

A. Keating, J. Abdi, Iran Rashedi, 2018, Stem cells.

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

P. Laneuville, N. Berinstein, D. Stewart, 2020 .

Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery.

R. Kandel, J. Medin, A. Keating, 2018, Cytotherapy.

RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia.

Steven M. Chan, Signy Chow, Rosemarie Tremblay-Lemay, 2021, Leukemia research.

Differential immunomodulatory effects of human bone marrow-derived mesenchymal stromal cells on natural killer cells.

A. Keating, P. Marcus, Y. Kosaka, 2019, Stem cells and development.

Cell adhesion molecules and their relation to (cancer) cell stemness.

E. Wiechec, E. Farahani, H. Patra, 2014, Carcinogenesis.

Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications

Maciej Kurpisz, K. Schulze-Osthoff, S. Panigrahi, 2008, Journal of Molecular Medicine.

The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation

S. Maddika, M. Los, J. Pryjma, 2006, Expert opinion on therapeutic targets.

Apoptin, a tumor-selective killer.

K. Schulze-Osthoff, F. Essmann, S. Panigrahi, 2009, Biochimica et biophysica acta.

Tumor Growth and Cell Proliferation

K. Schulze-Osthoff, S. Panigrahi, M. Los, 2009 .

Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide

A. Keating, Iran Rashedi, M. Saleh, 2017, Front. Immunol..

Targeting of solid tumors and blood malignancies by antibody-based therapies — EGFR-pathway as an example

M. Los, K. Krzemieniecki, K. Gawron, 2006, Central European Journal of Biology.

Peptides and Peptidomimetics as Cancer Therapy Sensitizing Agents

S. Banerji, S. Maddika, A. Zuse, 2008 .

A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features

R. Buckstein, M. Rauh, Hubert Tsui, 2023, Modern Pathology.

Priming Human Mesenchymal Stromal Cells to Enhance their Regenerative Potential

Iran Rashedi, 2017 .

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase‐dependent pathway

Saeid Ghavami, W. Chazin, S. Wesselborg, 2008, Journal of leukocyte biology.

Autoimmunity and apoptosis--therapeutic implications.

S. Ghavami, S. Panigrahi, M. Los, 2007, Current medicinal chemistry.

PD‐L1 expression predicts efficacy in the phase II SPiReL trial with MVP‐S, pembrolizumab, and low‐dose CPA in R/R DLBCL

P. Laneuville, N. Berinstein, D. Stewart, 2023, European journal of haematology.